CapEdge
Loading...
Advanced
What's new? Log in Free sign up
  • Home
  • Sectors & IndustriesSectors
  • Earnings
  • IPOs
  • SPACs
  • Transcripts
  • Insider
  • Institutional
  • Crypto
  • Screeners
  • Reddit
  • Splits
  • PRVA Dashboard
  • Financials
  • Filings
  • Transcripts
  • ETFs
  • Insider
  • Institutional
  • Shorts
  • News
  • Reddit

Privia Health (PRVA)

Company Profile
Privia Health™ is a technology-driven, national physician enablement company that collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual settings. iTS platform is led by top industry talent and exceptional physician leadership, and consists of scalable operations and end-to-end, cloud-based technology that reduces unnecessary healthcare costs, achieves better outcomes, and improves the health of patients and the well-being of providers.

Company profile

Ticker
PRVA
Exchange
NASDAQ
Website
www.priviahealth.com
Employees
Incorporated
Delaware
Location
Virginia
Fiscal year end
Dec 31
Sector
Manufacturing > Dental Laboratories
Industry (SIC)
Services - Health Services
LifeStance Health • InnovAge Holding • Sharecare • Oak Street Health • CRH Medical • GeneDx • UpHealth • U.S. Physical Therapy • Digital Health Acquisition • Pear Therapeutics ...
Former names
PH Group Parent Corp.
SEC CIK
0001759655
Corporate docs
Articles of Incorporation & Bylaws
Underwriting Agreements
Indentures
Material Contracts & Credit Agreements
Subsidiaries Lists
Subsidiaries
Bass Privia Management Company • Complete MD Solutions, LLC • Patient Health Advocacy Solutions, LLC • PH Group Holdings Corp. • PMG POL, LLC • PQN-Central Texas, LLC • PQN-Georgia, LLC • Privia Care Center, LLC • Privia Care Partners Georgia, LLC • Privia DC Metro Management Company, LLC ...

PRVA stock data

Analyst ratings and price targets

Last 3 months
Current price
Average target
$35.00
Low target
$28.00
High target
$43.00
Stifel
Initiated
Buy
$28.00
9 Dec 22
UBS
Initiated
Buy
$30.00
8 Dec 22
Canaccord Genuity
Maintains
Buy
$43.00
11 Nov 22
SVB Leerink
Maintains
Outperform
$39.00
11 Nov 22
Latest filings (excl ownership)
View all
8-K
Regulation FD Disclosure
9 Jan 23
8-K
Entry into a Material Definitive Agreement
21 Nov 22
424B7
Prospectus with selling stockholder info
17 Nov 22
424B7
Prospectus with selling stockholder info
15 Nov 22
S-3ASR
Automatic shelf registration
15 Nov 22
8-K
Privia Health Announces Change to its Board of Directors
15 Nov 22
8-K
Amendments to Articles of Incorporation or Bylaws
10 Nov 22
10-Q
2022 Q3
Quarterly report
10 Nov 22
8-K
Privia Health Reports Third Quarter 2022 Financial Results
10 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
Transcripts
View all
PRVA
Earnings call transcript
2022 Q3
13 Nov 22
PRVA
Earnings call transcript
2022 Q2
11 Aug 22
PRVA
Earnings call transcript
2022 Q1
14 May 22
PRVA
Earnings call transcript
2021 Q4
25 Mar 22
PRVA
Earnings call transcript
2021 Q3
8 Nov 21
PRVA
Earnings call transcript
2021 Q2
9 Aug 21
PRVA
Earnings call transcript
2021 Q1
28 May 21
Latest ownership filings
View all
4
William M Sullivan
24 Jan 23
4
William M Sullivan
17 Jan 23
4
Thomas Bartrum
17 Jan 23
4
William M Sullivan
10 Jan 23
4
William M Sullivan
27 Dec 22
4/A
David Mountcastle
20 Dec 22
3/A
David Mountcastle
20 Dec 22
4
William M Sullivan
15 Dec 22
4
William M Sullivan
12 Dec 22
4
William M Sullivan
29 Nov 22

Financial summary

Financial statements Chart PRVA financial data
Quarter (USD) Sep 22 Jun 22 Mar 22 Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 316.90 mm 316.90 mm 316.90 mm 316.90 mm 316.90 mm 316.90 mm
Cash burn (monthly) (no burn) 3.77 mm 1.52 mm 3.48 mm (no burn) (no burn)
Cash used (since last report) n/a 14.69 mm 5.94 mm 13.58 mm n/a n/a
Cash remaining n/a 302.21 mm 310.95 mm 303.32 mm n/a n/a
Runway (months of cash) n/a 80.2 203.9 87.1 n/a n/a

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q3 2022

PRVA institutional ownership history Ownership history
89.0% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 203 153 +32.7%
Opened positions 70 36 +94.4%
Closed positions 20 31 -35.5%
Increased positions 55 52 +5.8%
Reduced positions 55 46 +19.6%
13F shares Current Prev Q Change
Total value 3.25 bn 2.71 bn +19.7%
Total shares 101.70 mm 96.15 mm +5.8%
Total puts 134.50 k 665.10 k -79.8%
Total calls 303.60 k 138.20 k +119.7%
Total put/call ratio 0.4 4.8 -90.8%
Largest owners Shares Value Change
GS Goldman Sachs 28.01 mm $954.10 mm +0.4%
Pamplona Capital Partners III 20.02 mm $517.91 mm 0.0%
William M Sullivan 6.35 mm $164.25 mm 0.0%
Vanguard 4.82 mm $164.33 mm +7.1%
BK Bank Of New York Mellon 3.65 mm $124.44 mm -9.0%
BLK Blackrock 3.28 mm $111.85 mm +16.8%
T. Rowe Price Investment Management 2.77 mm $94.51 mm NEW
Riverbridge Partners 1.98 mm $67.51 mm -0.5%
FMR 1.44 mm $49.17 mm -0.9%
MS Morgan Stanley 1.41 mm $48.10 mm +76.5%
Largest transactions Shares Bought/sold Change
T. Rowe Price Investment Management 2.77 mm +2.77 mm NEW
T. Rowe Price 74.44 k -2.71 mm -97.3%
Senator Investment 600.00 k -900.00 k -60.0%
Citadel Advisors 949.28 k +899.33 k +1800.6%
STT State Street 0.00 -899.25 k EXIT
FHI Federated Hermes 690.68 k +690.68 k NEW
Point72 Asset Management 0.00 -660.30 k EXIT
MS Morgan Stanley 1.41 mm +611.92 k +76.5%
IVZ Invesco 984.51 k +497.66 k +102.2%
BLK Blackrock 3.28 mm +471.30 k +16.8%
Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

PRVA insider ownership history Insider history
Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
20 Jan 23 William M Sullivan Common Stock, $0.01 par value per share Sell Dispose S Yes Yes 25.36 18,153 460.36 k 5,808,777
12 Jan 23 Thomas Bartrum Common Stock, $0.01 par value per share Sell Dispose S No Yes 25.39 15,000 380.85 k 91,355
12 Jan 23 Thomas Bartrum Common Stock, $0.01 par value per share Option exercise Acquire M No No 2 15,000 30.00 k 106,355
12 Jan 23 Thomas Bartrum Stock Option (Right to Purchase) Common Stock Option exercise Dispose M No No 2 15,000 30.00 k 191,228
12 Jan 23 William M Sullivan Common Stock, $0.01 par value per share Sell Dispose S Yes Yes 25.02 6,038 151.07 k 5,826,930
6 Jan 23 William M Sullivan Common Stock, $0.01 par value per share Sell Dispose S Yes Yes 21.24 12,115 257.32 k 5,832,968
23 Dec 22 William M Sullivan Common Stock, $0.01 par value per share Sell Dispose S Yes Yes 23.39 12,115 283.37 k 5,845,083
Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

News

From Benzinga Pro
4 Analysts Have This to Say About Privia Health Group
9 Dec 22
Stifel Initiates Coverage On Privia Health Group with Buy Rating, Announces Price Target of $28
9 Dec 22
Stifel analyst Craig Jones initiates coverage on Privia Health Group (NASDAQ:PRVA) with a Buy rating and announces Price Target of $28.
UBS Initiates Coverage On Privia Health Group with Buy Rating, Announces Price Target of $30
8 Dec 22
UBS analyst Andrew Mok initiates coverage on Privia Health Group (NASDAQ:PRVA) with a Buy rating and announces Price Target of $30.
Reported Late Monday, NeoGenomics Announces Jeffrey S. Sherman Will Join The Company As Chief Financial Officer Effective December 7, Succeeding William Bonello Who Will Remain With The Company To Provide Transition And Onboarding Support For A Period Of Time
6 Dec 22
Target, Holley, Ferroglobe And Other Big Losers From Wednesday
17 Nov 22

Press releases

From Benzinga Pro
Privia Health Launches Two New Accountable Care Organizations
17 Jan 23
Privia's ACOs expands into Delaware and North CarolinaPrivia's ACOs now include 2,500+ Independent Providers Serving 191,700+ Medicare Beneficiaries in Medicare Shared Savings Program ARLINGTON, Va., Jan. 17, 2023
Privia Health Enters Delaware with Beebe Healthcare; Launches Ninth ACO
17 Jan 23
Privia partners with Beebe Healthcare, a community health system and medical groupACO to participate in 2023 Performance Year with ~12,400 lives ARLINGTON, Va., Jan. 17, 2023 (GLOBE NEWSWIRE) -- Privia Health Group,
NeoGenomics Announces Chief Financial Officer Transition
5 Dec 22
Jeffrey S. Sherman Appointed Chief Financial OfficerFT. MYERS, FL / ACCESSWIRE / December 5, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research services, today
Privia Health Announces Pricing of Secondary Offering
16 Nov 22
Privia Health Announces Secondary Offering
15 Nov 22
Finsight
Resources
  • Knowledgebase
  • Log In
  • Register
Company
  • About
  • Contact
  • Solutions
Products
  • Deal Roadshow
  • DealVDR
  • Evercall
  • Finsight.com
CapEdge
  • Earnings Calendar
  • Earnings Transcripts
  • EDGAR Filing Screener
  • IPO Calendar
  • Compliance
  • Privacy
  • Security
  • Terms
AngelList LinkedIn